| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 05/25/2000 | WO2000029620A1 Methods of facilitating vascular growth |
| 05/25/2000 | WO2000029609A1 N-terminally truncated her-2/neu protein as a cancer prognostic indicator |
| 05/25/2000 | WO2000029584A1 Antibody variants with higher binding affinity compared to parent antibodies |
| 05/25/2000 | WO2000029583A2 Immunoglobulin superfamily proteins |
| 05/25/2000 | WO2000029582A2 Cell surface receptor antigen vaccines |
| 05/25/2000 | WO2000029574A2 Inflammation-associated genes |
| 05/25/2000 | WO2000029569A1 Methods of diagnosing or treating neurological diseases |
| 05/25/2000 | WO2000029561A2 Nucleotide construct with optimised codons for an hiv genetic vaccine based on a primary, early hiv isolate and synthetic envelope |
| 05/25/2000 | WO2000029554A2 Compositions for preserving haptenized tumor cells for use in vaccines |
| 05/25/2000 | WO2000029447A1 Rhamm antagonist antibodies |
| 05/25/2000 | WO2000029446A1 Method for inhibiting macrophage infiltration using monoclonal anti-alpha-d-antibodies |
| 05/25/2000 | WO2000029445A1 Humanized antibody specific for human 4-1bb and pharmaceutical composition comprising same |
| 05/25/2000 | WO2000029443A1 Contraceptive antibody vaccines |
| 05/25/2000 | WO2000029438A1 Egf-like nucleic acids and polypeptides and uses thereof |
| 05/25/2000 | WO2000029435A1 12 human secreted proteins |
| 05/25/2000 | WO2000029434A2 PNEUMOCOCCAL CHOLINE BINDING PROTEINS, CbpG AND CbpD, DIAGNOSTIC AND THERAPEUTIC USES THEREOF |
| 05/25/2000 | WO2000029433A2 12-25-kda bacterial proteins and their 116-58 kda polymers for use e.g. in anti-tumor vaccines |
| 05/25/2000 | WO2000029432A1 Heliobacter pylori antigen |
| 05/25/2000 | WO2000029428A2 5t4 tumour-associated antigen for use in tumour immunotherapy |
| 05/25/2000 | WO2000029422A1 31 human secreted proteins |
| 05/25/2000 | WO2000029029A1 Compositions and methods for producing vascular occlusion |
| 05/25/2000 | WO2000029020A1 Anti-icam-r antibody-induced apoptosis |
| 05/25/2000 | WO2000029018A1 Combined vaccine against both hav and measle virus and method of producing it |
| 05/25/2000 | WO2000029016A1 Intradermal avian immunization with inactivated vaccines |
| 05/25/2000 | WO2000029015A2 INFLUENCING OF ANGIGENESIS USING CD66a |
| 05/25/2000 | WO2000029008A2 Hiv-specific t-cell induction |
| 05/25/2000 | WO2000019988A8 NOVEL Th2-SPECIFIC MOLECULES AND USES THEREOF |
| 05/25/2000 | WO2000015798A3 Mammalian transforming growth factor beta - 9 (ztgfss9) |
| 05/25/2000 | WO2000015788A3 Dna sequence encoding oncofetal ferritin protein |
| 05/25/2000 | WO2000015247A3 Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists |
| 05/25/2000 | WO2000014228A8 Neutral amino acid transporter and gene thereof |
| 05/25/2000 | WO2000010595A3 Medicaments for manipulating t-cell immune response |
| 05/25/2000 | WO2000001410A9 Methods of inhibiting proliferative diseases by inhibiting tgf-beta mediated angiogenesis |
| 05/25/2000 | WO2000000825A9 Detection and modulation of cellular immunity to immune privileged antigens |
| 05/25/2000 | WO1999055849A8 Tyrosine phosphatase ia-2, gad and rotavirus vp7 immunity |
| 05/25/2000 | WO1999053949A9 Combination of antigen pulsed apcs and interleukin 12 for tumor and viral therapy |
| 05/25/2000 | DE19853066A1 Use of hyaluronic acid fragments in vaccine production, especially for cancer treatment |
| 05/25/2000 | DE19840263C1 Papillomviren, Mittel zu deren Nachweis sowie zur Therapie von durch sie verursachten Erkrankungen Papillomaviruses means for their detection as well as for the treatment of diseases caused by them |
| 05/25/2000 | CA2369119A1 Nucleotide construct with optimised codons for an hiv genetic vaccine based on a primary, early hiv isolate and synthetic envelope |
| 05/25/2000 | CA2351729A1 Cell surface receptor antigen vaccines |
| 05/25/2000 | CA2351622A1 Polypeptide |
| 05/25/2000 | CA2351585A1 Influencing of angigenesis using cd66a |
| 05/25/2000 | CA2351524A1 12-25-kda bacterial proteins and their 116-58 kda polymers for use e.g. in anti-tumour vaccines |
| 05/25/2000 | CA2351522A1 Egf-like nucleic acids and polypeptides and uses thereof |
| 05/25/2000 | CA2351170A1 Humanized antibody specific for human 4-1bb and pharmaceutical composition comprising same |
| 05/25/2000 | CA2350917A1 Contraceptive antibody vaccines |
| 05/25/2000 | CA2350911A1 Hiv-specific t-cell induction |
| 05/25/2000 | CA2350785A1 31 human secreted proteins |
| 05/25/2000 | CA2350415A1 Inflammation-associated genes |
| 05/25/2000 | CA2350391A1 Method for inhibiting macrophage infiltration using monoclonal anti-alpha-d-antibodies |
| 05/25/2000 | CA2349581A1 Anti-icam-r antibody-induced apoptosis |
| 05/25/2000 | CA2349431A1 Intradermal avian immunization with inactivated vaccines |
| 05/25/2000 | CA2348824A1 12 human secreted proteins |
| 05/25/2000 | CA2348781A1 Compositions and methods for producing vascular occlusion |
| 05/25/2000 | CA2347833A1 Antibody variants with higher binding affinity compared to parent antibodies |
| 05/25/2000 | CA2340468A1 Methods of facilitating vascular growth |
| 05/24/2000 | EP1002865A1 Adipose specific protein |
| 05/24/2000 | EP1002862A1 Methods of diagnosing or treating neurological diseases |
| 05/24/2000 | EP1002545A1 Suppressive agent against expression of cell adhesion molecules |
| 05/24/2000 | EP1002544A1 Anti-edema agent |
| 05/24/2000 | EP1002543A1 Pharmaceutical compositions for the therapy of glioma or prostate cell proliferative disorders containing cyclic rgd compounds |
| 05/24/2000 | EP1002110A1 Immune responses against hpv antigens elicited by compositions comprising an hpv antigen and a stress protein or an expression vector capable of expression of these proteins |
| 05/24/2000 | EP1002108A2 Use of mhc class ii ligands as adjuvant for vaccination and of lag-3 in cancer treatment |
| 05/24/2000 | EP1002104A1 Novel metalloprotease |
| 05/24/2000 | EP1002093A1 Preparation and use of recombinant influenza a virus m2 constructs and vaccines |
| 05/24/2000 | EP1002092A1 Mimotopes of hypervariable region 1 of the e2 glycoprotein of hcv and uses thereof |
| 05/24/2000 | EP1002090A2 $i(ENTEROCOCCUS FAECALIS) POLYNUCLEOTIDES AND POLYPEPTIDES |
| 05/24/2000 | EP1002081A2 Delayed progression to aids by a missense allele of the ccr2 gene |
| 05/24/2000 | EP1002078A1 Method enabling readministration of aav vector via immunosuppresion of host |
| 05/24/2000 | EP1002070A1 Human atp-binding cassette transport protein |
| 05/24/2000 | EP1002068A1 Mutations in the myostatin gene cause double-muscling in mammals |
| 05/24/2000 | EP1002054A1 Process for the production of virus in cell cultures |
| 05/24/2000 | EP1001985A1 Kringle domains 1-5 of plasminogen, capable of modulating angiogenesis in vivo |
| 05/24/2000 | EP1001984A1 NOVEL ESTROGEN RECEPTOR $g(b) AND ISOFORMS |
| 05/24/2000 | EP1001983A1 NOVEL ESTROGEN $g(b) RECEPTOR AND ISOFORMS |
| 05/24/2000 | EP1001978A1 Angiotensin derivatives |
| 05/24/2000 | EP1001967A1 Componds and methods for treating and screening viral reactivation |
| 05/24/2000 | EP1001966A1 A senescence gene and its use in the treatment of cancer and other diseases |
| 05/24/2000 | EP1001964A1 Tango-78, tango-79, and tango-81 nucleic acid molecules and polypeptides |
| 05/24/2000 | EP1001815A1 Vectors derived from antibodies for transferring substances into cells |
| 05/24/2000 | EP1001809A1 Decreased fat absorption with an anti-lipase antibody |
| 05/24/2000 | EP1001808A1 Adjuvant compositions for vaccines |
| 05/24/2000 | EP1001807A1 Adoptive immunotherapy utilizing heat shock/stress protein-peptide complexes for prevention/treatment of cancer or infectious diseases |
| 05/24/2000 | EP1001806A1 Cellular vesicle called ''exosome'', preparation and use thereof in immune stimulation |
| 05/24/2000 | EP1001805A1 Methods for identifying antibodies and peptides useful in the treatment of septic shock and experimental arthritis and uses thereof |
| 05/24/2000 | EP0804070B1 Process of isolation of proteins from milk |
| 05/24/2000 | EP0652764B1 Use of synthetic peptides to induce tolerance to pathogenic t and b cell epitopes of autoantigens |
| 05/24/2000 | CN1254376A 端粒酶逆转录酶 Telomerase reverse transcriptase |
| 05/24/2000 | CN1254292A Anti-helicobacter vaccine composition for use by subdiahragmatic systemic route, and combined mucosal/parenteral immunization method |
| 05/24/2000 | CN1253953A Peptide immunogen, vaccine made of one for curing allergic reaction and its preparation method |
| 05/24/2000 | CN1253833A Cell adhesion molecule expression inhibitor |
| 05/24/2000 | CN1052733C Immuno-stimulatory monoclonal antibodies |
| 05/24/2000 | CN1052646C Capsule for curing gastropathy and its preparing method |
| 05/23/2000 | US6066719 Immunoglobulin heavy chain fragment associated with two light chains which each comprise a variable domain and form two functional antigen binding positions; for use in isolation of antibodies |
| 05/23/2000 | US6066717 RsbW-1 protein |
| 05/23/2000 | US6066623 Polynucleotide vaccine protective against malaria, methods of protection and vector for delivering polynucleotide vaccines |
| 05/23/2000 | US6066622 Immunomodulating peptides and methods of use |
| 05/23/2000 | US6066621 Response inhibiting peptide |
| 05/23/2000 | US6066503 Recombinant DNA molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections |
| 05/23/2000 | US6066502 Endothelin converting enzyme (ECE) |